# FDA Inspection 1167411 - Sharp Drugs, Inc. - April 06, 2022

Source: https://www.keypedia.com/records/fda_inspections/sharp-drugs-inc/93ad8486-f233-4a6b-9a74-ff9a7b412b0f
Source feed: FDA_Inspections

> FDA Inspection 1167411 for Sharp Drugs, Inc. on April 06, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1167411
- Company Name: Sharp Drugs, Inc.
- Inspection Date: 2022-04-06
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1060054 - 2018-07-13](https://www.keypedia.com/records/fda_inspections/sharp-drugs-inc/6234fcb3-51fd-41f9-8011-96f37b8a2c01)

Company: https://www.keypedia.com/companies/sharp-drugs-inc/514c5f6a-d54c-47e7-bf9c-e7a552270fd4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c